Only show
results from:

Sort results by:

Display preferences
212 results sorted by relevancy Results per page:
OPEXA THERAPEUTICS, INC. ANNOUNCES $5.1 MLN SECURITIES OFFER.
AsiaPulse News; Dec 11, 2009; 700+ Words ...NASDAQ) (RODM.NASDAQ) Opexa Therapeutics, Inc. Announces $5.1 Million...Dec. 10, 2009--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a...NY 10020. About Opexa Opexa Therapeutics, Inc. is dedicated to the development...
PharmaFrontiers Changes Name to Opexa Therapeutics; New Ticker Symbol is OPXA.
Business Wire; Jun 19, 2006; 700+ Words ...Shareholders Includes 1-for-10 Reverse Stock Split Opexa Therapeutics, (OTCBB:OPXA), a company involved in the...Company's name from PharmaFrontiers Corp. to Opexa Therapeutics, Inc. and effected a 1-for-10 (1:10) reverse...
Opexa Therapeutics Completes $3 Million Financing.
Business Wire; Aug 13, 2008; 700+ Words ...WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA...3.0 million. Opexa will use the proceeds...at Genometrix, Inc., principal with...manufactured in Opexa's in-house...About Opexa Opexa Therapeutics develops and commercializes...
www.StockMarketingInc.com :: Presents :: (Nasdaq:OPXA) Opexa Therapeutics, Inc., (Pinksheet:WDRP) Wanderport Corp., (OTCBB:IVOB) INVO BioScience, Inc., (Nasdaq:GNBT) Generex Biotechnology Corp.
M2 Presswire; Aug 7, 2009; 700+ Words ...Presents :: (Nasdaq:OPXA) Opexa Therapeutics, Inc., (Pinksheet:WDRP...com :: (Nasdaq:OPXA) Opexa Therapeutics, Inc., (Pinksheet:WDRP...OPXA - Opexa Therapeutics, Inc. TODAY'S NEWS ::Opexa...
Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program.
Vaccine Weekly; Sep 17, 2008; 700+ Words Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated...diagnostics and treatments for MS (see also Opexa Therapeutics, Inc.). Under terms of its collaboration with Opexa, the MRF will receive and analyze...
Opexa Therapeutics to Present Progress on Development of Monocyte-Derived Pancreatic Islet Cells for Diabetes.
Business Wire; May 7, 2007; 700+ Words ...Australia THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company...demonstrate significant advancement of Opexa's human stem cell program...this technology." About Opexa Therapeutics Opexa Therapeutics develops...
Opexa Therapeutics, Inc. Announces $5.1 Million Securities Offering.
Business Wire; Dec 10, 2009; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing a...Americas, 20th Floor, New York, NY 10020. About Opexa Opexa Therapeutics, Inc. is dedicated to the development of patient...
Opexa Therapeutics Appoints Dr. Mark Pittenger, Prominent Stem-Cell Researcher, to Scientific Advisory Board.
Business Wire; May 22, 2007; 700+ Words ...WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA...management team at Osiris Therapeutics, Inc. until 2005, is...developing cellular therapeutics, including stem cell...executive officer of Opexa, stated, "We are...
Morning Alert for Opexa Therapeutics, Inc.
M2 Presswire; Apr 4, 2007; 700+ Words ...Biotech News: Morning Alert for Opexa Therapeutics, Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:05042007 Morning Alert for Opexa Therapeutics, Inc (NASDAQ:OPXA) Opexa Therapeutics, Inc., a development stage biopharmaceutical...
Opexa Therapeutics Reports Third Quarter 2008 Financial Results.(Financial report)
Business Wire; Oct 23, 2008; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company...accomplishments. [TABLE OMITTED] "Opexa's Phase IIb TERMS study provided...code: 965022. About Opexa Therapeutics Opexa Therapeutics is a biotechnology...
Opexa Therapeutics Appoints Dr. Dawn McGuire, Prominent Neurologist, to Multiple Sclerosis Clinical Advisory Board.
Business Wire; Sep 26, 2007; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company...chief executive officer of Opexa, stated, "Dr. McGuire has...San Francisco. About Opexa Therapeutics Opexa Therapeutics develops...
Opexa Therapeutics Reports First Quarter 2008 Financial Results and Updates on Tovaxin(R) Phase IIb Study.
Business Wire; May 13, 2008; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company...chief executive officer of Opexa, commented, "The Phase IIb...public offering. About Opexa Therapeutics Opexa Therapeutics develops...
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis.(Clinical report)
Business Wire; Sep 11, 2007; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company...epitope profiles as identified by Opexa's Epitope Analysis Assay...chief executive officer of Opexa Therapeutics, stated, "I am pleased by...
Opexa Therapeutics Presents Monocyte-Derived Islet Cell Research at the International Society for Stem Cell Research Annual Meeting.
Business Wire; Jun 16, 2008; 700+ Words ...islets THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ: OPXA), a cell...derived islet technology (MDI). Opexa has previously shown that its...diabetes mellitus. About Opexa Therapeutics Opexa Therapeutics develops...
Opexa Therapeutics Closes First Tranche of Additional Financing.
Business Wire; Apr 16, 2009; 700+ Words ...Discussions THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company...approximately $1.1 million. Opexa will use the proceeds from the...cell research platform at Opexa Therapeutics has been focused on the development...
Opexa Therapeutics Announces Retirement of CEO David McWilliams.
Business Wire; Mar 21, 2008; 700+ Words ...Underway for Successor THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company leading in the...the Tovaxin([R]) Phase IIb trial." About Opexa Therapeutics Opexa Therapeutics develops and commercializes...
Opexa Therapeutics to Present at the Cambria Capital Investor Meeting.
Business Wire; Mar 24, 2008; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the...Cambria website at www.cambriacapital.com About Opexa Therapeutics Opexa Therapeutics develops and commercializes cell...
Opexa Therapeutics Presents Myelin Reactive T-Cell Research at the International Society of Cell Therapy Annual Meeting.
Business Wire; May 22, 2008; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the...patients treated in earlier clinical studies. About Opexa Therapeutics Opexa Therapeutics develops and commercializes...
Opexa Therapeutics Presents Tovaxin Phase I/II Data at the American Academy of Neurology 60th Annual Meeting.
Business Wire; Apr 15, 2008; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the...patients treated in earlier clinical studies. About Opexa Therapeutics Opexa Therapeutics develops and commercializes...
Opexa Therapeutics Reports First Quarter 2009 Financial Results and Closes Private Financing.(Financial report)
Business Wire; May 15, 2009; 700+ Words THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company...and chief executive officer of Opexa. "Gross proceeds from the...of the quarter. About Opexa Therapeutics Opexa Therapeutics develops...
212 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives